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Abstract— Contrast Enhanced Ultrasound (CEUS) is a sensitive imaging technique to assess tissue vascularity, that can be 
useful in the quantification of different perfusion patterns. This can particularly important in the early detection and 
differentiation of different types of arthritis. A Gamma-variate can accurately quantify synovial perfusion and it is flexible 
enough to describe many heterogeneous patterns. However, in some cases the heterogeneity of the kinetics can be such that even 
the Gamma model does not properly describe the curve, especially in presence of recirculation or of an additional slow-flow 
component. 
In this work we apply to CEUS data both the Gamma-variate and the single compartment recirculation model (SCR) which 
takes explicitly into account an additional component of slow flow. The models are solved within a Bayesian framework. 
When dividing the patients into two groups (rheumatoid arthritis and polyarticular RA-like psoriatic arthritis vs. other arthritis 
types), the median value of the parameter indicating the presence of slow-flow is significantly different (0.12 vs 0.09, p<0.002), 
whereas when performing ANOVA to check the differences among each type of arthritis, the median is no more different, but 
the parameter distribution is (p<0.05). 
 
 
DESCRIPTION OF PURPOSE 
Contrast-enhanced Ultrasound (CEUS) is an imaging technique that uses microbubbles as contrast agent to visualize 
and assess tissue vascularization and perfusion. In particular, CEUS has been widely used in the study of the arthritis 
disease to non-invasively assess synovial neo-vascularization and local perfusion variations for early detection and grading 
of the pathology [1–5]. CEUS data are generally quantified at the region of interest (ROI) level, i.e. analyzing the time 
activity curve (TAC) obtained by averaging all pixel TACs within a specific user-defined region. In a previous work, we 
have tackled the CEUS quantification problem at the pixel level and we have demonstrated that pixel-wise quantification 
allows such an effective characterization of different perfusion patterns that they can be then used to discriminate between 
arthritis subtypes [6]. Moreover, we showed that a physiologically motivated perfusion curve, such as the Gamma-variate 
model, can accurately quantify synovial perfusion and it is more flexible than a mono-exponential or logarithmic model 
(generally employed for CEUS kinetic description) to describe many heterogeneous patterns. However, in some cases the 
heterogeneity of the CEUS kinetics can be such that even a Gamma-variate model does not properly describe the time 
courses, as in presence of an apparent trapping of the microbubbles in newly formed vasculature, when characterized by 
high tortuosity [7,8]. This apparent trapping can also be explained by the limited temporal duration of the CEUS scan, that 
prevents the identification of a very slow washout from the data. This problem has already been considered in other 
contrast-based imaging techniques (e.g. in dynamic susceptibility contrast magnetic resonance imaging, DSC-MRI), where 
the original Gamma-variate was augmented with its integral to explicitly model the recirculation of the contrast agent 
(single compartment recirculation, SCR) [9,10]. However, nothing similar has ever been investigated for CEUS images 
quantification. 
In the current work, we solve both the Gamma model and the SCR model at pixel level within a Bayesian framework using 
Variational Bayesian estimator, already applied to MR [11] and positron emission tomography (PET) data [12]. Prior 
information for the pixels were generated automatically from the image data using the estimates obtained by applying the 
model to a set of regional time courses solved with a nonlinear estimator in a hierarchical, user-independent, approach 
[12,13].  
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METHODS 
The classical Gamma-variate model will consider negligible any irreversible component of the contrast agent, compared 
to the general picture of the system dynamics.  
An alternative model to describe CEUS kinetics is the single recirculation component (SCR), previously proposed for 
DSC-MRI perfusion imaging. This model can be used to describe the irreversible component in CEUS:  
 
𝑐𝑆𝐶𝑅(𝒑, 𝑡) = 𝑐𝑔𝑎𝑚𝑚𝑎(𝑡) +
𝑎1
𝐴𝑈𝐶𝑔
∫ 𝑐𝑔𝑎𝑚𝑚𝑎(𝜏)𝑑𝜏  𝑡 ≥ 𝑡0
𝑡
𝑡0
 
 
with the parameters 𝒑𝑺𝑪𝑹 =[𝑎0, 𝛼, 𝑡0 , 𝛽, 𝑎1] where 𝑎1 is the scaling factor (normalized by the area under the curve 𝐴𝑈𝐶𝑔 
of 𝑐𝑔𝑎𝑚𝑚𝑎(𝑡) to range between 0 and 1. The integral term describes the slow-flow in the synovial perfusion.  
 
Variational Bayes estimation 
In the Bayesian framework, we want to estimate the posterior distribution of the parameters 𝑃(𝜣|𝒚, 𝑚), where 𝜣 is the 
vector of the parameters of a chosen model 𝑚 from a set of measured data 𝒚. In real applications, the numerical integrations 
needed for the direct computation of the posterior are usually intractable. Here we implement a Variational Bayesian (VB) 
approach, already proposed for medical imaging analysis [11,12], which, in brief, exploits a mean field approximation of 
the true posterior, i.e. 𝑄(𝜣|𝒎) = ∑ 𝑄𝑖𝑖 (𝜣𝒊|𝒎). The problem therefore shifts to the minimization of the divergence 
between the approximated and the true posterior, which is achieved by maximizing a quantity called Free Energy (which 
acts as the lower bound of the log model evidence, that can be used for model selection [16]).  
A key point in Bayesian modeling is the prior definition: we implemented an automatically user independent approach to 
derive the priors from the data. We defined the prior distributions as a multivariate Gaussian distribution for the vector of 
model parameters 𝒑 and an uninformative Gamma distribution for the variance scaling factor 𝜙. The priors for the model 
parameters were obtained from a preliminary estimation on 6 regions of interest within the synovia, identified by functional 
clustering (k-means partitioning method [14,15]) and setting the variance of the priors as 50% of the estimated mean priors 
value: 
 
𝑃(𝒑)~𝒩(𝒑; 𝒑𝟎, (0.5 𝒑𝟎)
2) 
 
DATASET 
Data from previously reported studies [6] of 115 subjects affected by arthritis were used in the current study. The cohort 
included 53 patients with rheumatoid arthritis and 58 patients with non-rheumatoid (non-RA). Among the non-RA patients, 
21 had distal predominant (dpPSA) and 9 polyarticular RA-like psoriatic arthritis (PSA), 8 undifferentiated 
spondyloarthritis (uSPA), and 8 had arthritis in connective tissue disease (CTD). 
All patients showed signs of inflammatory finger joint involvement: the joint with the highest disease activity was chosen 
for CEUS examination. All patients gave their informed consent to the examination, to the intravenous administration of 
the contrast agent and to the participation of the study that was approved by the local institutional ethical committee. Each 
subject underwent a 2-min CEUS study with a 7-MHz transducer US device (MyLab25, EsaOte) equipped with Contrast 
tuned Imaging (CnTI; Esaote), according to the procedure described in [17]. Gray-scale US (anatomical B-mode image) 
were acquired to define the boundaries of the synovial tissue (semi-automatically outlined by the radiologists as in [18]). 
CEUS images were motion corrected and coregistered to the anatomical image, normalized, and extracted the pixels within 
the synovial boundaries showing a significant enhancement [6]. We excluded sixteen subjects with no active pixels from 
the analysis. 
 
  
Fig. 1 Boxplots showing the empirical distribution of the estimated parameter 𝑎1, linked to the presence and amount of a 
slow-flow component in the synovia. On the left panel, the RA and RA-like psoriatic arthritis are grouped together against 
the other, whereas on the right panel all diseases are plotted separately. 
 
 
RESULTS 
The estimated parameters using the SCR model allow the identification of the presence of a slow-flow component in the 
synovial perfusion through the quantification of the parameter 𝑎1. The amount of this component seems related to 
different types of angiogenetic processes, that are characteristics of different types of arthritis diseases. When 
subdividing the available data into those affected by rheumatoid arthritis and polyarticular RA-like psoriatic arthritis and 
those affected by other types of arthritis, both t-test (p<0.002) and a rank-sum test (p<0.002) suggest that the value of 𝑎1 
is significantly different in the two populations. The distribution of its value is shown in the boxplots of Fig 1. Then, we 
tried to assess by means of an analysis of variance (ANOVA) if the parameter 𝑎1 can be significantly different in the 
populations identified by all types of arthritis in the data. As can be seen in Fig. 1, right panel, the median values are not 
significantly different among all diseases (p=0.29), but the distributions of its value are (p<0.05).  
 
NEW OR BREAKTHROUGH WORK TO BE PRESENTED 
A new model for the description of contrast-enhanced ultrasound data integrating a slow-flow component has been 
proposed and applied in the analysis of the perfusion patterns of arthritis patients. The slow-flow component seems 
relevant for the characterization of the different types of disease. 
 
CONCLUSIONS 
We propose a more complex model for describing the perfusion kinetics of ultrasound contrast within the synovia, 
accounting for a slow-flow component similar to what appears to be recirculation in DSC-MRI. The mean value of the 
parameter describing the amplitude of this component is able to improve the characterization of different arthritis,  
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